Research News

Markey Joins Nationwide Effort to Encourage Resumption of Cancer Screening, Treatment

Feb 1, 2021, 1:18 PM

The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.

Markey Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation

Jan 12, 2021, 8:18 AM

A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.

Williams Named Assistant Director for Cancer Health Equity at Markey

Nov 10, 2020, 8:22 AM

A major initiative of Williams and the Markey Community Impact Office will be the organization and expansion of Markey’s research and outreach portfolio that is focused on reducing cancer and other health disparities based on race/ethnicity, socioeconomic status, etc.

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Oct 29, 2020, 8:29 AM

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Evers_Mark_Director%20Markey%20Cancer%20Ctr_1.jpg

Evers Elected to the National Academy of Medicine

Oct 20, 2020, 8:18 AM

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

UK Study Highlights Need for Genetic Testing for Kentucky Patients with Lung Cancer

Sep 23, 2020, 9:58 AM

Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib.

Markey Joins National Cancer Consortium to Address the Impact of COVID-19 on Cancer

Sep 22, 2020, 8:12 AM

Markey has joined a consortium of 17 cancer centers across the country to better understand how COVID-19 has impacted cancer prevention, detection and care.

Cancer, COVID and the Kentucky Economy: How 'Sweet Annie' Could Make an Impact

Aug 11, 2020, 8:19 AM

Artemisia annua or "Sweet Annie" has been used as a medicinal herb for centuries. With potential to treat a variety of cancers & even COVID-19, this plant is more relevant than ever & UK is showing how we can take it from Kentucky fields to the lab to our patients.

Kuhs Named Co-Leader of Markey Cancer Prevention & Control Research Program

Aug 4, 2020, 8:21 AM

As a cancer prevention researcher trained in both basic laboratory science and epidemiology, Kuhs’ experience allows her to apply basic science findings to population-based studies, which will be essential to lowering cancer rates in the hardest-hit areas of the state.

Outreach Shows Progress, Promise in Fighting Oral Cancer Despite COVID-19

Jul 29, 2020, 8:26 AM

Kentucky has one of the nation's highest incidences of oral cancer, according to the National Institutes of Health, and the prevalence of oral cancer in the targeted counties is as much as 54% higher than the state average.

Filter News

Unit

News type

Topic

Series